PATENT CLAIM ANALYSIS

Application Number: 15934299
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["546", "133000"]

Abstract:
Provided herein are compounds and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of conditions associated with inhibition of HDAC (e.g., HDAC2).

Claim (Index 1):
A compound of the formula: or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.21429
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15741609', '15867982', '14417477', '15321410', '15786134']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7465328912908893
- 35 USC 102 Novelty (BERT): 0.550915738807693
- Combined Prediction Score: 0.7269711760425697
- Mean Citation Score: 306.012022
- Max Citation Score: 398.32266
- Similarity Product: 348.91267242809766

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test